Whole-body MRI to assess subclinical cardiovascular disease
and frailty development
Bharath Ambale Venkatesh1, Jason Ortman2, Jaclyn Sesso2, Yoko Kato2, Elzbieta Chamera2, Jennifer Wagner3, Yoshimori Kassai4, and Joao Lima2
1Radiology, Johns Hopkins University, Baltimore, MD, United States, 2Johns Hopkins University, Baltimore, MD, United States, 3Canon Medical Research USA, Mayfield Village, OH, United States, 4Canon Medical Systems, Kanagawa, Japan
Whole body non-contrast magnetic resonance angiography and Dixon imaging hold potential for monitoring and quantitative assessment of global plaque burden and cardiometabolic disease in frailty.
This abstract and the presentation materials are available to 2020 meeting attendees and eLibrary customers only;
a login is required.